- Life Sciences
- Conference
World ADC San Diego
Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend this conference and present on how Tempus can support your needs.
Robust Tumor Organoid Screening to Accelerate Discovery of Antibody-Drug Conjugates
Over 600 commercially qualified tumor organoid models characterized by the Tempus xT comprehensive NGS test that can be used in standardized or custom drug screensA pan-cancer organoid panel, Pan60™, consisting of sixty predefined primary and metastatic tumor organoids for targeted drug screens across nine indications, is ideal for screening ADC targetsModel ADC responses across a broad range of experimental scenarios, including free-payload and isotype control normalization, custom dose curve assessments, and optimized time intervals
Brandon Mapes, Senior Computational Biologist
Learn more↗Schedule a meeting with us
We'll be in touch shortly.